Azelaic acid + Vehicle foam
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Papulopustular Rosacea
Conditions
Papulopustular Rosacea
Trial Timeline
Jan 1, 2008 → Jun 1, 2008
NCT ID
NCT00617903About Azelaic acid + Vehicle foam
Azelaic acid + Vehicle foam is a phase 2 stage product being developed by Bayer for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT00617903. Target conditions include Papulopustular Rosacea.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00617903 | Phase 2 | Completed |
Competing Products
18 competing products in Papulopustular Rosacea